| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| R&D Expense | $5.2M | +296.8% |
| SG&A Expense | $7.1M | +95.5% |
| Operating Income | -$12.3M | -148.8% |
| Interest Expense | $47K | -67.3% |
| Pre-tax Income | -$12.4M | -145.0% |
| Net Income | -$12.4M | -145.0% |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.1M | +629.0% |
| Current Assets | $14.4M | +394.9% |
| Total Assets | $14.5M | +398.4% |
| Current Liabilities | $1.2M | +29.5% |
| Total Liabilities | $1.2M | +29.5% |
| Stockholders' Equity | $13.4M | +563.3% |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.6M | -143.9% |
| Investing Cash Flow | -$106K | -205.5% |
| Financing Cash Flow | $18.9M | +323.7% |